Booster Vaccination After Neonatal Priming with Acellular Pertussis Vaccine

Journal of Pediatrics

Volumn 156, Issue 4, 2010, Pages 675-678

  Knuf, Markus ^a   Schmitt, Heinz Josef ^a   Jacquet, Jeanne Marie ^b   Collard, Alix ^b   Kieninger, Dorothee ^a   Meyer, Claudius U ^a   Siegrist, Claire Anne ^c   Zepp, Fred ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; NEUTRALIZING ANTIBODY;

ARTICLE; CLINICAL TRIAL; FEBRILE CONVULSION; FEVER; GASTROENTERITIS; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE SWELLING; NEWBORN; OTITIS MEDIA; PRIORITY JOURNAL; TREATMENT DURATION; VACCINATION;

DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION, SECONDARY; INFANT; INFANT, NEWBORN; PERTUSSIS VACCINE; PROGNOSIS; VACCINATION; VACCINES, ACELLULAR; WHOOPING COUGH;

EID: 77949472573     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.12.019     Document Type: Article

References (9)

1. Knuf M., Schmitt H.J., Wolter J., Schuerman L., Jacquet J.M., Kieninger D., et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr 152 (2008) 655-660
2. Belloni C., De Silvestri A., Tinelli C., Avanzini M.A., Marconi M., Strano F., et al. Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics 111 (2003) 1042-1045
3. Halasa N.B., O'Shea A., Shi J.R., LaFleur B.J., and Edwards K.M. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr 153 (2008) 327-332
4. Siegrist C.A. Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunization. J Pediatr 153 (2008) 305-307
5. Käyhty H. Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines. Biologicals 22 (1994) 397-402
6. Tichmann I., Grunert H., Habash S., Priedel H., Schult R., Pfletschinger U., et al. Persistence of antibodies in children primed with two different hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccines and evaluation of booster vaccination. Hum Vaccine 2 (2006) 249-254
7. Adkins J.C., and Wagstaff A.J. Recombinant hepatitis B vaccine: a review of its immunogenicity and protective efficacy against hepatitis B. BioDrugs 10 (1998) 137-158
8. Saenger R., Maechler G., Potreck M., Zepp F., Knuf M., Habermehl P., et al. Booster vaccination with hexavalent DTaP-HBV-IPV/Hib vaccine in the second year of life is as safe as concomitant DTaP-IPV/Hib + HBV administered separately. Vaccine 23 (2005) 1135-1143
9. Knuf M., Habermehl P., Faber J., Bock H.L., Sänger R., Bogaerts H., et al. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvants as a fourth (booster-) dose in the second year of life. Vaccine 24 (2006) 5627-5636